Company Filing History:
Years Active: 2001
Title: Jaemog Soh: Innovator in Interferon Gamma Research
Introduction
Jaemog Soh is a notable inventor based in Highland Park, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the area of interferon gamma and its receptor. His innovative work has led to the development of a patent that addresses critical aspects of genetic manipulation and therapeutic applications.
Latest Patents
Jaemog Soh holds a patent titled "Accessory factory function for interferon gamma and its receptor." This invention encompasses several key components: (a) a 540 kb YAC that encodes necessary species-specific factors, substituting for human Chromosome 21 to reconstitute the Hu-IFN-gamma receptor-mediated induction of class I HLA antigens; (b) the construction of a plasmid to integrate a selective marker for antibiotic G418 resistance into YACs, facilitating the manipulation of human genomic DNA; (c) two fragmentation vectors, pSE1 and pSE2, developed for targeting YACs containing human genomic DNA; (d) a chromosomal fragmentation procedure to produce a deletion set of YACs from a parental YAC known to map to Chromosome 21q; and (e) the isolation of cDNA clones that encode the necessary species-specific factor.
Career Highlights
Jaemog Soh is affiliated with the University of Medicine and Dentistry of New Jersey, where he has been involved in groundbreaking research. His work has not only advanced scientific understanding but has also paved the way for potential therapeutic applications in medicine.
Collaborations
Throughout his career, Jaemog Soh has collaborated with esteemed colleagues such as Sidney Pestka and Serguei V Kotenko. These partnerships have further enriched his research and contributed to the advancement of biotechnology.
Conclusion
Jaemog Soh's innovative contributions to the field of interferon gamma research exemplify the impact of dedicated inventors in biotechnology. His patent and collaborative efforts continue to influence the scientific community and hold promise for future advancements in medical therapies.